None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) aged 19-85 years; (2) 11-point numerical-rating-scale (NRS) pain score of 4 or higher in lower extremity (3) Diagnosed with a complex regional pain syndrome (type 1 or 2) or post traumatic pain syndrome (4) More than 1.5 ? temperature increase at diagnostic block in 2 times trial with 1.5ml of local anesthetics.
Exclusion criteria
Exclusion criteria: (1) Refusal of the patient (2) Vascular disease at lower extremity (ex, thromboangitis obliterans) (3) previous lumbar sympathetic neurolysis (thermocoagulation, chemical neurolysis) (4) coagulopathy (5) systemic infection or local infection at lumbar puncture site (6) significant deformity at lumbar spine (7) neoplasm (8) known allergic reaction with amide type local anesthetics (9) cognitive dysfunction (not understanding of numerical-rating-scale) (10) known allergic reaction with botulinum toxin (11) pregnant or feeding women (12) If the patient has participated in another clinical trial within 30 days before screening, or if passed no longer than 5-fold half-life of the clinical trial drug of the participating clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the change in the relative temperature difference on the blocked sole compared with the contralateral sole | — |
Secondary
| Measure | Time frame |
|---|---|
| Temperature change in group A vs B at ipsilateral and contralateral leg;success rate;Korean CISS (Cold Intolerance Symptom Severity) Questionnaire;NRS pain score change;pain related with procedure;Medication change;5-pointed satisfaction scale;Blood flow velosity at popliteal artery using ultrasound;Maintenance of temperature change in group A vs B at ipsilateral leg | — |
Countries
Korea, Republic of
Contacts
Seoul National University Hospital